Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now?
Key takeaways
- Ricardo Pillai Sun, May 3, 2026 at 11:37 PM GMT+7 3 min read HIMS Is HIMS a good stock to buy?
- (Hims) is positioned as a vertically integrated digital healthcare platform transitioning from reactive treatment to preventive, data-driven medicine.
- Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now? Ricardo Pillai Sun, May 3, 2026 at 11:37 PM GMT+7 3 min read HIMS Is HIMS a good stock to buy? We came across a bullish thesis on Hims & Hers Health, Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc. s share was trading at $29.76 as of April 21st. HIMS’s trailing and forward P/E were 60.80 and 72.99 respectively according to Yahoo Finance.
Hims & Hers Health, Inc. (Hims) is positioned as a vertically integrated digital healthcare platform transitioning from reactive treatment to preventive, data-driven medicine. The Q4 FY2025 update highlights early evidence of customers proactively engaging through diagnostics, lifting ARPU and reinforcing the shift toward preventative engagement rather than symptom-led care. Despite ongoing legal scrutiny and slowing subscriber growth, management indicates that the core weight loss exposure is limited and unlikely to materially affect the broader business model.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich